Trial Profile
A study of four-factor prothrombin complex concentrate in patients with and without liver disease when used for the treatment or prophylaxis of significant bleeding
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Mar 2018
Price :
$35
*
At a glance
- Drugs Prothrombin complex concentrate (Primary)
- Indications Blood coagulation disorders
- Focus Therapeutic Use
- 12 Mar 2018 New trial record